Leonid Timashev
Inquirer · DISC type cdLeonid Timashev serves as a Director and Biotechnology Analyst at RBC Capital Markets, specializing in the neurology, oncology, and cardiology sectors. He leverages a deep scientific background, holding a Ph. D. in Molecular Cell Biology and Genetics from The Rockefeller University and has obtained Series 86 and 87 certifications.
Leonid demonstrates a passion for translating scientific concepts into business applications. He was the runner-up in the Tri-Institutional Bench to Bedside Initiative for an entrepreneurial pitch for "SmartCuff, " a medical device concept. He also actively helps advanced degree candidates transition from academia into finance careers.
Unique fact: Leonid has co-authored multiple peer-reviewed scientific papers on the molecular structure and integrity of telomeres, the protective caps on the ends of chromosomes.
Read the full overview →How Leonid shows up
They care equally about the product and its potential impact. They respond well to confident salespeople. They don’t always try to control the conversation but neither do they like yielding it fully.
Topics Leonid cares about
Work history
Media appearances
DISC profile (public)
Calculativeness (C)
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Other RBC Capital Markets Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.